Julia R Kurowski1, Lee Nedkoff2, Deborah E Schoen3, Matthew Knuiman4, Paul E Norman5, Tom G Briffa4. 1. Podiatric Medicine Unit, School of Surgery, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Australia. 2. School of Population Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Australia. Electronic address: lee.nedkoff@uwa.edu.au. 3. Western Australian Centre for Rural Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Australia. 4. School of Population Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Australia. 5. School of Surgery, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Australia.
Abstract
AIMS: To examine temporal trends in lower extremity amputations in people with type 1 diabetes, type 2 diabetes and cardiovascular disease (CVD) without diabetes in Western Australia (WA) from 2000 to 2010. METHODS: We used linked health data to identify all non-traumatic lower extremity amputations in adults aged ≥20 years with diabetes and/or CVD from 2000 to 2010 in WA. Annual age- and sex-standardised rates of total, initial and recurrent amputations, stratified by major and minor status, were calculated for type 1 and type 2 diabetes, and CVD without diabetes, from the at-risk population for each group. Age- and sex-adjusted trends were estimated from Poisson regression models. RESULTS: 5891 lower extremity amputations were identified. Peripheral vascular disease (71%), hypertension (70%) and chronic kidney disease (60%) were highly prevalent. Average annual rates of total amputations were 724, 564 and 66 per 100,000 person-years in type 1, type 2 diabetes and CVD without diabetes respectively. Rates of initial amputations fell significantly by 2.4%/year (95% CI -3.5, -1.4) in type 2 diabetes, with similar declines for type 1 diabetes and CVD without diabetes (interaction p=0.96), driven by large falls in major amputations. There was limited improvement in recurrence rates overall, with recurrent minor amputations increasing significantly in type 2 diabetes (+3.5%/year, 95% CI +1.3%, +5.7%). CONCLUSION: Lower extremity amputation rates have declined at a population level in people with diabetes and CVD without diabetes, suggesting improvements in prevention and management for this high-risk patient group, however limited declines in recurrent amputations requires further investigation. Crown
AIMS: To examine temporal trends in lower extremity amputations in people with type 1 diabetes, type 2 diabetes and cardiovascular disease (CVD) without diabetes in Western Australia (WA) from 2000 to 2010. METHODS: We used linked health data to identify all non-traumatic lower extremity amputations in adults aged ≥20 years with diabetes and/or CVD from 2000 to 2010 in WA. Annual age- and sex-standardised rates of total, initial and recurrent amputations, stratified by major and minor status, were calculated for type 1 and type 2 diabetes, and CVD without diabetes, from the at-risk population for each group. Age- and sex-adjusted trends were estimated from Poisson regression models. RESULTS: 5891 lower extremity amputations were identified. Peripheral vascular disease (71%), hypertension (70%) and chronic kidney disease (60%) were highly prevalent. Average annual rates of total amputations were 724, 564 and 66 per 100,000 person-years in type 1, type 2 diabetes and CVD without diabetes respectively. Rates of initial amputations fell significantly by 2.4%/year (95% CI -3.5, -1.4) in type 2 diabetes, with similar declines for type 1 diabetes and CVD without diabetes (interaction p=0.96), driven by large falls in major amputations. There was limited improvement in recurrence rates overall, with recurrent minor amputations increasing significantly in type 2 diabetes (+3.5%/year, 95% CI +1.3%, +5.7%). CONCLUSION: Lower extremity amputation rates have declined at a population level in people with diabetes and CVD without diabetes, suggesting improvements in prevention and management for this high-risk patient group, however limited declines in recurrent amputations requires further investigation. Crown
Authors: Rosana E Norman; Michelle Gibb; Anthony Dyer; Jennifer Prentice; Stephen Yelland; Qinglu Cheng; Peter A Lazzarini; Keryln Carville; Karen Innes-Walker; Kathleen Finlayson; Helen Edwards; Edward Burn; Nicholas Graves Journal: Int Wound J Date: 2015-12-03 Impact factor: 3.315
Authors: Tejas P Singh; Joseph V Moxon; Michael T Meehan; Rhondda Jones; Yvonne Cadet-James; Jonathan Golledge Journal: BMC Endocr Disord Date: 2021-05-21 Impact factor: 2.763
Authors: Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg Journal: Diabetologia Date: 2018-08-31 Impact factor: 10.122
Authors: Mohamad A Hussain; Mohammed Al-Omran; Konrad Salata; Atul Sivaswamy; Thomas L Forbes; Naveed Sattar; Badr Aljabri; Ahmed Kayssi; Subodh Verma; Charles de Mestral Journal: CMAJ Date: 2019-09-03 Impact factor: 8.262
Authors: Qinglu Cheng; Peter A Lazzarini; Michelle Gibb; Patrick H Derhy; Ewan M Kinnear; Edward Burn; Nicholas Graves; Rosana E Norman Journal: Int Wound J Date: 2016-08-04 Impact factor: 3.315